Categories: Life Science | Format :
Global Diaphragm Pacing Therapy System Market Overview
The Global Diaphragm Pacing Therapy System Market size is estimated to reach $9.41 Million by 2026, growing at a CAGR of 5.1% over the forecast period of 2021-2026.
Therapy for those who require the use of a ventilator and cannot breathe on their own. The Diaphragmatic Pacing System (DPS) can give part-time or full-time breathing assistance to those who ordinarily need a mechanical ventilator. In addition, the patient, family, and carers will be informed about the whole treatment process.
Compared to mechanical ventilators, the diaphragm pacemaker is more accurate and comfortable, and it lowers the risk of upper airway infections, including ventilator-associated pneumonia. The deployment of diaphragm pacing treatment systems is also fuelled by favorable regulatory rules and approvals.
Impact of COVID-19 on Diaphragm Pacing Therapy Systems Market
In collaboration with governments throughout the world, pharmaceutical and biotech businesses are striving to combat the COVID-19 epidemic, from vaccine research to planning for obstacles in the pharmaceutical supply chain. Approximately 115 vaccine candidates and 155 compounds are currently being developed in the R&D pipeline.
Furthermore, routinely used medications like hydroxychloroquine have shown a massive increase in demand for COVID-19 treatment. Due to the increased demand for these treatments, makers of COVID-19 management pharmaceuticals have a lot of potential because many wealthy nations are running out of them. Because of the need for COVID-19 vaccines and treatment medications, the pharmaceutical and biotechnology sectors are likely to increase significantly in the future.
Key Takeaways from Global Diaphragm Pacing Therapy System Market Report:
Market Dynamics
Driver:
Increasing prevalence of Spinal Cord Injuries drives the market demand
Increased incidence of SCI (Spinal Cord Injuries) and rising occurrences of ALS are two primary market driving factors for the worldwide Diaphragm Pacing Therapy System market (Amyotrophic lateral sclerosis).
According to a 2019 study from the National Spinal Cord Injury Statistical Center, roughly 17,730 new SCI cases are reported per year, and nearly 249,000 to 363,000 people in the United States are now living with SCI.
Furthermore, the worldwide market is exhibiting considerable growth as a result of increasing technical breakthroughs and increasing product innovations and launches in the category. The advantages of diaphragm pacing treatment systems, such as reduced reliance on mechanical ventilators and the ability for patients to breathe more effectively and naturally without the use of ventilators, are expected to drive market growth throughout the forecast period.
Challenge:
The surge in usage of Hospital Applications is set to limit the market growth.
The diaphragm pacing treatment system is mainly used in hospitals, ambulatory surgical centers, and other settings. Hospitals are the most significant end consumers in the market among them. This is attributable to SCIs, which have grown in popularity as the quantity and frequency of instances involving SCIs have increased.
Furthermore, accidents or wrecks while driving or participating in sports activities increase the number of patients admitted to hospitals who require diaphragm pacing treatment devices.
By product, the market for External Diaphragm Pacemaker is estimated to grow at the highest CAGR during the forecast period.
Based on Product, Global Diaphragm Pacing Therapy System Market is segmented into External Diaphragm Pacemaker and Diaphragm Pacemaker. External Diaphragm Pacemaker dominated the market in 2020 and is also set to be fastest growing with a CAGR of 5.4% over the forecast period 2021-2026.
Because of the development in treating illnesses such as cervical spinal cord injury and congenital central hypoventilation syndrome, the external diaphragm pacemaker segment is gaining favor. In addition, the diaphragm pacemaker reduces the risk of power interruptions and the need for an additional power source, while the ease of mobility and silent operation boost market expansion.
By Application, the market for Spinal Cord Injury is estimated to grow at the highest CAGR during the forecast period.
By Applications, Spinal Cord Injury dominated the market in 2020 and is set to be fastest growing with a CAGR of 5.6% over the forecast period 2021-2026. Every year, roughly 17,000 new spinal cord injury cases are recorded in the United States, according to the National Spinal Cord Injury Statistical Center.
Furthermore, an increase in accidents falls, and injuries sustained while participating in sports or recreational activities has increased the frequency of spinal cord damage and the number of patients affected, leading to a demand for diaphragm pacing treatment devices.
Furthermore, the rising prevalence of amyotrophic lateral sclerosis will likely enhance the diaphragm pacing treatment system’s market expansion. Amyotrophic lateral sclerosis is most frequent among the elderly, with 5,000 new cases identified each year in the United States.
The Asia Pacific to account for the largest market share during the forecast period
North America dominated the Global Diaphragm Pacing Therapy System Market with a share of 45.9% in 2020. Because of the high incidence of respiratory problems such as sleep apnea, amyotrophic lateral sclerosis, and spinal cord injuries in the area, the market is likely to rise strongly throughout the forecast period.
Furthermore, rising patient disposable incomes and improved healthcare expenditures are likely to contribute to market expansion in the area.
However, Asia Pacific is set to be the fastest-growing over 2021-2026. This is due to an increase in the prevalence of respiratory diseases, increased healthcare spending, supporting government efforts, increased focus on R&D activities, and technology progress in improving healthcare infrastructure.
Key Market Players
Key Players in Global Diaphragm Pacing Therapy System Market consist of Lungpacer Medical Inc.; Avery Biomedical Devices, Inc.; Synapse Biomedical; Atrotech , among others.
Developments
In April 2020, The FDA granted permission to Lung pacer Medical. This was approved for emergency usage permission. As a result, patients with COVID-19 are being treated using diaphragm pacing treatment devices.
Report Coverage and Scope
The report “Global Diaphragm Pacing Therapy System Market”, by Research Informatic covers an in-depth detailed analysis for the following segment, which are covered under the scope.
By Product
By Applications
Geography
Global Diaphragm Pacing Therapy System Market Growth, Trend and Forecast 2021-2028
Chapter 1 Diaphragm Pacing Therapy System Market Overview
1.1 Product Overview and Scope of Diaphragm Pacing Therapy System
1.2 Diaphragm Pacing Therapy System Market Segmentation by Type
1.2.1 Global Production Market Share of Diaphragm Pacing Therapy System by Type in 2020
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Diaphragm Pacing Therapy System Market Segmentation by Application
1.3.1 Diaphragm Pacing Therapy System Consumption Market Share by Application in 2020
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Diaphragm Pacing Therapy System Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Diaphragm Pacing Therapy System (2014-2028)
Chapter 2 Global Economic Impact on Diaphragm Pacing Therapy System Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
Chapter 3 Global Diaphragm Pacing Therapy System Market Competition by Manufacturers
3.1 Global Diaphragm Pacing Therapy System Production and Share by Manufacturers (2020 and 2020)
3.2 Global Diaphragm Pacing Therapy System Revenue and Share by Manufacturers (2020 and 2020)
3.3 Global Diaphragm Pacing Therapy System Average Price by Manufacturers (2020 and 2020)
3.4 Manufacturers Diaphragm Pacing Therapy System Manufacturing Base Distribution, Production Area and Product Type
3.5 Diaphragm Pacing Therapy System Market Competitive Situation and Trends
3.5.1 Diaphragm Pacing Therapy System Market Concentration Rate
3.5.2 Diaphragm Pacing Therapy System Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
Chapter 4 Global Diaphragm Pacing Therapy System Production, Revenue (Value) by Region (2014-2021)
4.1 Global Diaphragm Pacing Therapy System Production by Region (2014-2021)
4.2 Global Diaphragm Pacing Therapy System Production Market Share by Region (2014-2021)
4.3 Global Diaphragm Pacing Therapy System Revenue (Value) and Market Share by Region (2014-2021)
4.4 Global Diaphragm Pacing Therapy System Production, Revenue, Price and Gross Margin (2014-2021)
4.5 North America Diaphragm Pacing Therapy System Production, Revenue, Price and Gross Margin (2014-2021)
4.6 Europe Diaphragm Pacing Therapy System Production, Revenue, Price and Gross Margin (2014-2021)
4.7 China Diaphragm Pacing Therapy System Production, Revenue, Price and Gross Margin (2014-2021)
4.8 Japan Diaphragm Pacing Therapy System Production, Revenue, Price and Gross Margin (2014-2021)
4.9 Southeast Asia Diaphragm Pacing Therapy System Production, Revenue, Price and Gross Margin (2014-2021)
4.10 India Diaphragm Pacing Therapy System Production, Revenue, Price and Gross Margin (2014-2021)
Chapter 5 Global Diaphragm Pacing Therapy System Supply (Production), Consumption, Export, Import by Regions (2014-2021)
5.1 Global Diaphragm Pacing Therapy System Consumption by Regions (2014-2021)
5.2 North America Diaphragm Pacing Therapy System Production, Consumption, Export, Import by Regions (2014-2021)
5.3 Europe Diaphragm Pacing Therapy System Production, Consumption, Export, Import by Regions (2014-2021)
5.4 China Diaphragm Pacing Therapy System Production, Consumption, Export, Import by Regions (2014-2021)
5.5 Japan Diaphragm Pacing Therapy System Production, Consumption, Export, Import by Regions (2014-2021)
5.6 Southeast Asia Diaphragm Pacing Therapy System Production, Consumption, Export, Import by Regions (2014-2021)
5.7 India Diaphragm Pacing Therapy System Production, Consumption, Export, Import by Regions (2014-2021)
Chapter 6 Global Diaphragm Pacing Therapy System Production, Revenue (Value), Price Trend by Type
6.1 Global Diaphragm Pacing Therapy System Production and Market Share by Type (2014-2021)
6.2 Global Diaphragm Pacing Therapy System Revenue and Market Share by Type (2014-2021)
6.3 Global Diaphragm Pacing Therapy System Price by Type (2014-2021)
6.4 Global Diaphragm Pacing Therapy System Production Growth by Type (2014-2021)
Chapter 7 Global Diaphragm Pacing Therapy System Market Analysis by Application
7.1 Global Diaphragm Pacing Therapy System Consumption and Market Share by Application (2014-2021)
7.2 Global Diaphragm Pacing Therapy System Consumption Growth Rate by Application (2014-2021)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries
Chapter 8 Diaphragm Pacing Therapy System Manufacturing Cost Analysis
8.1 Diaphragm Pacing Therapy System Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Diaphragm Pacing Therapy System
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Diaphragm Pacing Therapy System Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Diaphragm Pacing Therapy System Major Manufacturers in 2020
9.4 Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
Chapter 12 Global Diaphragm Pacing Therapy System Market Forecast (2021-2028)
12.1 Global Diaphragm Pacing Therapy System Production, Revenue Forecast (2021-2028)
12.2 Global Diaphragm Pacing Therapy System Production, Consumption Forecast by Regions (2021-2028)
12.3 Global Diaphragm Pacing Therapy System Production Forecast by Type (2021-2028)
12.4 Global Diaphragm Pacing Therapy System Consumption Forecast by Application (2021-2028)
12.5 Diaphragm Pacing Therapy System Price Forecast (2021-2028)
Chapter 13 Appendix
The Diaphragmatic Pacing System (DPS) can give part-time or full-time breathing assistance to those who would ordinarily need a mechanical ventilator. The patient, family, and carers will be informed about the whole treatment process.
The Global Diaphragm Pacing Therapy System Market size is estimated to reach $9.41 Million by 2026 growing at a CAGR of 5.1% over the forecast period of 2021-2026.
Increased incidence of SCI (Spinal Cord Injuries) and rising occurrences of ALS are two main market driving factors for the worldwide Diaphragm Pacing Therapy System market (Amyotrophic lateral sclerosis).
Lungpacer Medical Inc.; Avery Biomedical Devices, Inc.; Synapse Biomedical; Atrotech , among others
North America dominated the Global Diaphragm Pacing Therapy System Market with share of 45.9% in 2020. Because of the high incidence of respiratory problems such as sleep apnea, amyotrophic lateral sclerosis, and spinal cord injuries in the area, the market is likely to rise strongly throughout the forecast period.
By Product, market for External Diaphragm Pacemaker is estimated to grow at the highest CAGR during the forecast period
Published On:Jan 2021
Base Year:2020
Historical Data:2017 - 2019
No of Pages:250
Diaphragm Pacing Therapy System Market Size, Share...
RD Code : HP22